Push and pull factors of medical tourism development in AsiaPac determine specific obstacles and challenges in this market and definitely presented a lot of opportunities. When building your strategy to enter the medical tourism market in AsiaPac, the key questions to ask are: what are the particular demands and medtech needs in this sector; how […]
Home > Archives for Bart Van den Mooter
About Bart Van den Mooter
Posts by Bart Van den Mooter:
In the coming two years (2018-2020), the market will grow and evolve rapidly, and there are many factors to consider in order to stay on-top and ahead, i.e. to optimize and revise your products’ market presence proactively, and to successfully address the procurers’ needs.
In the first part of our investigation into medical tourism in Asia-Pac we introduced the market, its dynamics, trends, and pull and push factors. In this second part of the series, we explore to greater length specific countries and investor groups within the AsiaPac region, and their characteristics and activities pertaining to medical tourism. We […]
AsiaPac is the fastest growing region in the global medtech market. This growth is fueled by public healthcare reforms, but even more so by the rapidly expanding private sector. The driving and crucial role of medical tourism in this growth is often cleanly forgotten and omitted.
The US, Japan and the EU are the world’s largest medtech markets. Patients have comparable buying power and they can rely on a widely available and high quality healthcare (HC) system. At the same time, the markets differ substantially in regards to care provision culture and business dynamics.
It is widely accepted that new technologies are responsible for both rising healthcare (HC) costs as well as for improved clinical outcomes. Research shows that there are substantial differences in how new products and techniques gain access to different markets, such as those in the US, Germany and Japan.
Comparing Purchasing Processes for Surgical Devices and Medical Equipment in the US, Japan and Germany
The US, Japan and Germany are the world’s largest medtech markets. Together they account for around €210 bn, or almost half of the global market. Each nation has a slightly (or vastly) individualized approach to procuring the medtech used in their healthcare system; i.e. there are varying weights granted to the participating stakeholders and decision […]
In this article, we will compare the US (with around 325 m inhabitants), Japan (130 m) and the largest European market, Germany (85 m), in terms of surgical practices, and assess the effects of the differences between these countries on the respective medtech markets.
For 2016, the estimated global market of hybrid ORs was valued at €3.9bn. At a forecasted CAGR of 16.6%, the market is expected to reach €13.3bn in 2025. What makes this market especially interesting is that the hybrid suites require many different medtech devices and components combining a wide range of therapeutic and diagnostic functionalities. […]
In this article, we will describe the factors and mechanisms that drive the income and buying power of hospitals in China and elaborate where medtech companies are likely to find the most attractive segments.